Previous Close | 30.06 |
1-Year Change | -12.05% |
6-Months Change | 9.11% |
3-Months Change | 2.73% |
Moving Avg (50d) | 30.764 |
Moving Avg (200d) | 29.967 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.702B |
Beta (3-Years) | 1.33 |
Revenue Growth (ttm) | 22.4% |
Net Profit Margin (ttm) | -15.57% |
Return On Assets (ttm) | -5.12% |
EPS (ttm) | -1 |
PE Ratio (ttm) | -30.06 |
Dividend Yield | % |
Asset Description: | OrthoPediatrics Corp. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-17 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
30.661 | 31.563 | 32.164 | 33.066 | 34.569 | 36.072 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |